Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00379574
What this trial is testing

Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

Who this might be right for
Lymphoma, Large-Cell, DiffuseLymphoma, B-Cell
Asan Medical Center 49
Early research (Phase 1)Study completedNCT01471210
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma
Bristol-Myers Squibb 124
Not applicableLooking for participantsNCT06796517
What this trial is testing

Immunotherapy in Lymphoma

Who this might be right for
Relapsed/refractory High Grade B Cell LymphomaHigh Grade B-cell LymphomaDiffuse Large B Cell Lymphoma Relapsed+2 more
Sung-Soo Park 72
Early research (Phase 1)Study completedNCT03763149
What this trial is testing

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

Who this might be right for
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd. 20
Early research (Phase 1)UnknownNCT03821363
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Advanced Solid Tumors or Lymphoma
Sinocelltech Ltd. 206
Early research (Phase 1)Ended earlyNCT01163071
What this trial is testing

Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid Tumors
Celgene 60
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Early research (Phase 1)Study completedNCT05040932
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Who this might be right for
Cancer
Eucure (Beijing) Biopharma Co., Ltd 8
Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Early research (Phase 1)UnknownNCT05606380
What this trial is testing

A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma

Who this might be right for
Solid Tumor and Lymphoma
Shanghai Henlius Biotech 11
Early research (Phase 1)UnknownNCT03731390
What this trial is testing

GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma

Who this might be right for
Tumor, SolidLymphoma
Chinese Academy of Medical Sciences 30
Not applicableLooking for participantsNCT06895291
What this trial is testing

Whole Body MRI in Oncology

Who this might be right for
LymphomaAdvanced Prostate CancerAdvanced Breast Cancer+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,000
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Large-scale testing (Phase 3)WithdrawnNCT01652261
What this trial is testing

Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)

Who this might be right for
Hodgkin Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Ended earlyNCT02061449
What this trial is testing

Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
NYU Langone Health 3
Early research (Phase 1)Looking for participantsNCT06150664
What this trial is testing

Of CTX-8371 in Patients With Advanced Malignancies

Who this might be right for
Non Small Cell Lung CancerTriple Negative Breast CancerHodgkin Lymphoma+2 more
Compass Therapeutics 85
Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Early research (Phase 1)Ended earlyNCT04214093
What this trial is testing

AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaMultiple Myeloma+1 more
AstraZeneca 9
Early research (Phase 1)Study completedNCT00428545
What this trial is testing

Bevacizumab and Bortezomib in Patients With Advanced Malignancy

Who this might be right for
Advanced MalignancyLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 104
Next Page